Eutilex.Co.,Ltd

KOSDAQ:A263050 Stock Report

Market Cap: ₩71.7b

Eutilex.Co.Ltd Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Byoung S. Kwon

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownership15.1%
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

Despite Lacking Profits Eutilex.Co.Ltd (KOSDAQ:263050) Seems To Be On Top Of Its Debt

Aug 07
Despite Lacking Profits Eutilex.Co.Ltd (KOSDAQ:263050) Seems To Be On Top Of Its Debt

Is Eutilex.Co.Ltd (KOSDAQ:263050) A Risky Investment?

Apr 15
Is Eutilex.Co.Ltd (KOSDAQ:263050) A Risky Investment?

Could The Eutilex.Co.,Ltd. (KOSDAQ:263050) Ownership Structure Tell Us Something Useful?

Feb 05
Could The Eutilex.Co.,Ltd. (KOSDAQ:263050) Ownership Structure Tell Us Something Useful?

CEO

Byoung S. Kwon

2.3yrs

Tenure

Dr. Byoung S. Kwon, Ph.D. is the Founder and serves as Chief Executive Officer of Eutilex Co., Ltd. Dr. Kwon serves as Endowed Investigator at the Division of Cell and Immunobiology of R&D Center for Cance...